Publications by authors named "Timothy Devos"

Claim this Profile
R
Real-world outcomes in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia treated with ponatinib - final 6-year results from a Belgian registry.
Timothy Devos, Dries Deeren, Koen Theunissen, Dominik Selleslag, Benjamin Bailly

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophils in BCR::ABL1 negative MPN: Contributors or bystanders of fibrosis?
Gaël Vermeersch, Mieke Gouwy, Paul Proost, Sofie Struyf, Timothy Devos

Blood Rev· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study.
Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Timothy Devos

Ther Adv Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.
Yan Beauverd, Jean-Christophe Ianotto, Kyaw Htin Thaw, Marta Sobas, Parvis Sadjadian, Timothy Devos

Leukemia· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular therapies for the prevention and treatment of acute graft-versus-host disease.
Daniel Peltier, Van Anh Do-Thi, Timothy Devos, Bruce R Blazar, Tomomi Toubai

Stem Cells· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic models for prediction of perioperative allogeneic red blood cell transfusion in adult cardiac surgery: A systematic review and meta-analysis.
Raf Van den Eynde, Annemarie Vrancken, Ruben Foubert, Krizia Tuand, Thomas Vandendriessche, Timothy Devos

Transfusion· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCL8 and its cognate receptors CXCR1/CXCR2 in primary myelofibrosis.
Gael Vermeersch, Paul Proost, Sofie Struyf, Mieke Gouwy, Timothy Devos

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.
Vikas Gupta, Stephen Oh, Timothy Devos, Viviane Dubruille, John Catalano

Leuk Lymphoma· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib in patients with polycythemia vera resistant and/or intolerant to hydroxyurea: European observational study.
Alexandre Theocharides, Heinz Gisslinger, Valerio De Stefano, Vincenzo Accurso, Alessandra Iurlo, Timothy Devos

Eur J Haematol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib.
Ruben Mesa, Srdan Verstovsek, Uwe Platzbecker, Vikas Gupta, David Lavie, Timothy Devos

Haematologica· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis.
Stephen T Oh, Srdan Verstovsek, Vikas Gupta, Uwe Platzbecker, Timothy Devos

EJHaem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Hubert Schrezenmeier, Austin Kulasekararaj, Lindsay Mitchell, Régis Peffault de Latour, Timothy Devos

Ann Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the relationship between anellovirus load and clinical variables in hospitalized COVID-19 patients: Implications for immune activation and inflammation.
Marijn Thijssen, Timothy Devos, Geert Meyfroidt, Marc Van Ranst, Mahmoud Reza Pourkarim

IJID Reg· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.
John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos

J Clin Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
Britta Höchsmann, Regis Peffault de Latour, Anita Hill, Alexander Röth, Timothy Devos

Ann Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline heterozygous SH2B3-mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation.
Gaël Vermeersch, Timothy Devos, Helena Devos, Frédéric Lambert, Bruce Poppe

EJHaem· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of blast phase in myelofibrosis according to anemia severity.
Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Timothy Devos

EJHaem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion.
Quentin Van Thillo, Barbara Dewaele, Jolien De Bie, Lucienne Michaux, Timothy Devos

Br J Haematol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the Human Blood Virome in Iranian Multiple Transfused Patients.
Marijn Thijssen, Gholamreza Khamisipour, Mohammad Maleki, Timothy Devos, Guangdi Li

Viruses· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe ARDS due to Ruxolitinib discontinuation syndrome: case presentation and literature review.
Jona F Houthuys, Alexander P Wilmer, Marijke Peetermans, Philippe Meersseman, Timothy Devos

Heliyon· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical management.
Gaël Vermeersch, Michel Delforge, Violaine Havelange, Carlos Graux, Lucienne Michaux, Timothy Devos

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Timothy Devos

Leukemia· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in the SIMPLIFY-1 and SIMPLIFY-2 phase 3 trials of momelotinib in patients with myelofibrosis.
Ruben Mesa, Claire Harrison, Stephen T Oh, Aaron T Gerds, Vikas Gupta, Timothy Devos

Leukemia· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III MANIFEST-2: pelabresib + ruxolitinib vs placebo + ruxolitinib in JAK inhibitor treatment-naive myelofibrosis.
Claire N Harrison, Vikas K Gupta, Aaron T Gerds, Raajit Rampal, Srdan Verstovsek, Timothy Devos

Future Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Timothy Devos, An Haekens

Tijdschr Gerontol Geriatr· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis